SCHEMBL7380689

SCHEMBL7380689

CC(=O)Nc1ccc(NC(C)=O)c(C(N)=O)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.55
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
CA12 O43570 1/20 0.50
BRD4 O60885 1/20 0.50
NR1I2 O75469 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
MB P02144 1/20 0.50
CYP1A1 P04798 1/20 0.50
CA3 P07451 1/20 0.50
CYP3A4 P08684 1/20 0.50
RARG P13631 1/20 0.50
TSHR P16473 1/20 0.50
ALOX5AP P20292 1/20 0.50
CA4 P22748 1/20 0.50
CA7 P43166 1/20 0.50
NR1I3 Q14994 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7376765 0.86 SIRT2 (0.59) SIRT2ALDH1A1MEN1MAPTKMT2A
SCHEMBL27704672 0.85 ALDH1A1 (0.53) ALDH1A1MEN1MAPTKMT2ACA12
SCHEMBL11803827 0.84 KDM4E (0.67) ALDH1A1MEN1MAPTKMT2ACA12
SCHEMBL11796396 0.82 KDM4E (0.65) ALDH1A1MEN1MAPTKMT2ACA12
SCHEMBL551783 0.82 SMN1; SMN2 (0.54) SIRT2ALDH1A1MEN1MAPTKMT2A
SCHEMBL13254952 0.82 SMN1; SMN2 (0.53) SIRT2MAPTKDM4ESMN1; SMN2NPC1
SCHEMBL8474270 0.81 PEPD (0.53) SIRT2ALDH1A1MEN1MAPTKMT2A
SCHEMBL8803244 0.81 SIRT2 (0.50) SIRT2ALDH1A1MEN1MAPTKMT2A
SCHEMBL11796400 0.81 HTT (0.49) ALDH1A1MEN1MAPTKMT2ACA12
SCHEMBL2902152 0.81 SMN1; SMN2 (0.53) SIRT2ALDH1A1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1079820-A1 BENZAMIDE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-03-07 EP disclosed
WO-1999059569-A1 BENZAMIDE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 1999-11-25 WO disclosed
EP-0912171-A1 BENZAMIDE TREATMENT OF DEMENTIA ASSOCIATED WITH AIDS VIRUS (HIV-1) INFECTION CENTAUR PHARMACEUTICALS, INC. (US) 1999-05-06 EP disclosed
WO-1997038684-A1 BENZAMIDE TREATMENT OF DEMENTIA ASSOCIATED WITH AIDS VIRUS (HIV-1) INFECTION CENTAUR PHARMACEUTICALS, INC. (US) 1997-10-23 WO disclosed